Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,723 | -73,158 | -52,735 | -32,298 | -15,236 |
| Depreciation Amortization | 129 | -41 | -127 | -148 | -87 |
| Accounts payable and accrued liabilities | 3,021 | -2,670 | -2,342 | -4,346 | 2,820 |
| Other Working Capital | 2,023 | -7,934 | -10,388 | -9,224 | -2,601 |
| Other Operating Activity | -39 | 12,543 | 9,963 | 8,684 | -821 |
| Operating Cash Flow | $-22,589 | $-71,260 | $-55,629 | $-37,332 | $-15,925 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,228 | -142,530 | -78,390 | -97,665 | -19,053 |
| Investing Cash Flow | $-29,228 | $-142,530 | $-78,390 | $-97,665 | $-19,053 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 19,730 | 19,730 | 19,730 | 19,730 |
| Common Stock Issued | 960 | 284,693 | 146,036 | 144,269 | 35,268 |
| Other Financing Activity | 0 | 1 | 0 | 0 | 0 |
| Financing Cash Flow | $960 | $304,424 | $165,766 | $163,999 | $54,998 |
| Beginning Cash Position | 115,358 | 24,724 | 24,724 | 24,724 | 24,724 |
| End Cash Position | 64,501 | 115,358 | 56,471 | 53,726 | 44,744 |
| Net Cash Flow | $-50,857 | $90,634 | $31,747 | $29,002 | $20,020 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,589 | -71,260 | -55,629 | -37,332 | -15,925 |
| Free Cash Flow | -22,589 | -71,260 | -55,629 | -37,332 | -15,925 |